Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 7/20 | 0.76 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.76 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | CD69 | Q07108 | 1/20 | 0.55 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.46 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.46 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19605034 | 1.00 | LGALS3 (0.76) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL16129525 | 1.00 | LGALS3 (0.76) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL25626439 | 1.00 | LGALS3 (0.76) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL23425804 | 0.92 | LGALS3 (0.66) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL16887725 | 0.92 | MAPK1 (0.71) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL888110 | 0.92 | MAPK1 (0.71) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL10298053 | 0.92 | MAPK1 (0.71) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL15354501 | 0.92 | MAPK1 (0.71) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL10298024 | 0.92 | MAPK1 (0.71) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL17988585 | 0.92 | MAPK1 (0.71) | LGALS3LGALS8LGALS4MAPK1CD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230181607-A1 | THIOSACCHARIDES FOR USE IN TREATING CORONAVIRUS INFECTION | The University of the Regents of California (US) | 2023-06-15 | — | — | US | disclosed |
| WO-2021231397-A1 | THIOSACCHARIDES FOR USE IN TREATING CORONAVIRUS INFECTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-11-18 | — | — | WO | disclosed |
| EP-3851109-A1 | THIOSACCHARIDE MUCOLYTIC AGENTS | The Regents of the University of California (US) | 2021-07-21 | — | — | EP | disclosed |
| US-11021506-B2 | Thiosaccharide mucolytic agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-06-01 | — | — | US | disclosed |
| EP-2968215-B1 | THIOSACCHARIDE MUCOLYTIC AGENTS | UNIV CALIFORNIA (US) | 2021-05-05 | — | — | EP | disclosed |
| US-20190290225-A1 | AIRWAY MUCUS IMPACTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-09-26 | — | — | US | disclosed |
| US-20180111955-A1 | THIOSACCHARIDE MUCOLYTIC AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11021506-B2 | Thiosaccharide mucolytic agents | MUC1, TREH, FUT6 | LGALS3 134/4885LGALS8 109/4885LGALS4 89/4885 |
| US-20180111955-A1 | THIOSACCHARIDE MUCOLYTIC AGENTS | MUC1, TREH, FUT6 | LGALS3 134/4885LGALS8 109/4885LGALS4 89/4885 |
| US-20190290225-A1 | AIRWAY MUCUS IMPACTION | MUC1, IL5, CYSLTR2 | LGALS3 99/4885LGALS8 460/4885LGALS4 72/4885 |
| US-20230181607-A1 | THIOSACCHARIDES FOR USE IN TREATING CORONAVIRUS INFECTION | TMPRSS4, ACE, ACE2 | LGALS3 43/4885LGALS8 33/4885LGALS4 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.